Market Publishers has released a new report titled ‘Future US Hematology and Flow Cytometry Market Outlook.’
Venture Planning Group had prepared the report. According to the report, the commercialization of novel products is likely to be the driving factor for the future growth of the hematology and flow cytometry market. The United States will remain the largest market for hematology with a 50% share in the global market.
Growing research and commercialization in the life science field, including stem cell research, pharmacogenomics, genomics and proteomics, have driven the growth of high-throughput techniques such as the flow cytometry. However, limitations such as high equipment cost hinder the growth of the flow cytometry market.
The advancement in high sensitivity point-of-care tests and bench-top high throughput hematology analyzers will drive the growth of the global hematology market during the forecast period.
The report covers key technological, regulatory, economic, social and demographic trends that will have an impact on the hematology and flow cytometry market in the United States in the coming decade. It includes five- and ten-year sales and volume forecast data for key flow cytometry and hematology tests. It provides estimated yearly placements and installed base data for key automated and semi-automated flow cytometers and hematology analyzers.
The comprehensive report reviews existing instrumentation technologies and compares the features of more than 60 analyzers. It provides five- and ten-year instrument and reagent sales forecast data, and market shares and sales of key instrument and reagent suppliers. It features the review of existing and promising technologies and their prospective market applications, product advancement opportunities for consumables, instruments and auxiliary products, profiles of key existing and up-and-coming suppliers, and strategic recommendations and business opportunities for suppliers.
Source: http://marketpublishers.com